Crossref
DPP-4i, GLP-1RA and SGLT2i have differing autoimmune disease risks
Reactions Weekly · 18.07.2026 · 2119 (1) · 10-10
DOI: 10.1007/s40278-026-96309-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reactions Weekly, online erschienen am 18.07.2026. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). DPP-4i, GLP-1RA and SGLT2i have differing autoimmune disease risks. Reactions Weekly, 2119(1), 10-10. https://doi.org/10.1007/s40278-026-96309-2
Vancouver
DPP-4i, GLP-1RA and SGLT2i have differing autoimmune disease risks. Reactions Weekly. 2026;2119(1):10-10. doi:10.1007/s40278-026-96309-2
BibTeX
@article{euvimed2026,
title = {DPP-4i, GLP-1RA and SGLT2i have differing autoimmune disease risks},
journal = {Reactions Weekly},
year = {2026},
volume = {2119},
number = {1},
pages = {10--10},
doi = {10.1007/s40278-026-96309-2}
}
EUVIMED